448 related articles for article (PubMed ID: 35155266)
1. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
Liu Y; Ao X; Wang Y; Li X; Wang J
Front Oncol; 2022; 12():841411. PubMed ID: 35155266
[TBL] [Abstract][Full Text] [Related]
2. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
[TBL] [Abstract][Full Text] [Related]
3. Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review.
Li Z; Lü M; Zhou Y; Xu L; Jiang Y; Liu Y; Li X; Song M
Onco Targets Ther; 2021; 14():503-518. PubMed ID: 33500626
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer.
Liu Y; Ao X; Ji G; Zhang Y; Yu W; Wang J
Front Oncol; 2021; 11():768918. PubMed ID: 34912714
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.
Zhou X; Ao X; Jia Z; Li Y; Kuang S; Du C; Zhang J; Wang J; Liu Y
Front Oncol; 2022; 12():951864. PubMed ID: 36059609
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
10. Retracted Article: Long non-coding RNA GACAT1 alleviates doxorubicin and vincristine resistance through a PTEN/AKT/mTOR/S6K1 regulatory pathway in gastric cancer.
Ding H; Sun J; Li R; Wang G
RSC Adv; 2019 Mar; 9(14):8048-8055. PubMed ID: 35521206
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation.
Zhao J; Liu Y; Huang G; Cui P; Zhang W; Zhang Y
Am J Cancer Res; 2015; 5(3):907-27. PubMed ID: 26045977
[TBL] [Abstract][Full Text] [Related]
12. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer.
Liu Y; Ding W; Yu W; Zhang Y; Ao X; Wang J
Mol Ther Oncolytics; 2021 Dec; 23():458-476. PubMed ID: 34901389
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
15. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications.
Tan H; Zhang S; Zhang J; Zhu L; Chen Y; Yang H; Chen Y; An Y; Liu B
Theranostics; 2020; 10(19):8880-8902. PubMed ID: 32754285
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma.
Feng YN; Li BY; Wang K; Li XX; Zhang L; Dong XZ
Front Mol Biosci; 2022; 9():977280. PubMed ID: 36310592
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application.
Gao Y; Wang JW; Ren JY; Guo M; Guo CW; Ning SW; Yu S
World J Gastroenterol; 2020 Jun; 26(24):3401-3412. PubMed ID: 32655264
[TBL] [Abstract][Full Text] [Related]
20. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
Shao Z; Gao D; Chen L; Ding W; Yu Q
Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
